window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 9, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Genomics and sequencing

  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Genomics and sequencing

    Countable Labs raises $26m to expand Countable PCR platform

    Countable Labs has raised $26 million in an oversubscribed financing [...]

    June 6, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    23andMe study links genetics to GLP-1 weight loss outcomes and side effects

    This Nature-published study from the 23andMe Research Institute identifies genetic [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Primerdesign and Origin partner on rectal mucus DNA extraction for colorectal cancer detection

    Primerdesign and Origin Sciences partner to develop a DNA extraction [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Genomics and sequencing,Therapeutic Areas

    Circio presents new in vivo data showing enhanced circVec-AAV gene expression in eye

    Circio Holding ASA, a biotechnology company developing circular RNA-based gene [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Genomics and sequencing

    New England Biolabs launches Monarch Mag Cell-free DNA extraction kit for scalable cfDNA isolation

    New England Biolabs has launched the Monarch Mag Cell-free DNA [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Insitro completes first AI-enabled human genetics study of brown adipose tissue, identifies differentiated obesity targets

    insitro has completed what it says is the first population-scale [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Genomics and sequencing

    SPT Labtech adds automated Twist Bioscience NGS library preparation workflows to firefly platform

    SPT Labtech has announced the availability of validated automated workflows [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    PacBio HiFi adopted to study sudden unexplained death in childhood and advance precision therapies for rare diseases

    PacBio is supporting two research initiatives that use its HiFi [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Flagship Pioneering signs new agreements with ProFound Therapeutics and Quotient Therapeutics with GSK collaboration

    Flagship Pioneering has announced that ProFound Therapeutics and Quotient Therapeutics [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Genomics and sequencing

    Sheba, Mount Sinai and NVIDIA launch AI collaboration to decode unexplored regions of the human genome

    ARC Innovation at Sheba Medical Center and the Icahn School [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • LotusDx opens Aberdeen R&D laboratory to advance at-home STI testing
    Categories: Biotech & Pharma Business, Medical devices
  • Deep Science Ventures and Medicines Discovery Catapult target blood-brain barrier challenge
    Categories: Biotech & Pharma Business, Central Nervous System, Drug Discovery & Development
  • Phase 3 data support PSMA-targeted radiopharmaceutical combination approach in advanced prostate cancer
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top